Tumor necrosis factor-α-converting enzyme (TACE) is a metalloprotease which can shed several cytokines from the cell membrane, including receptor activator of NF-κB ligand (RANKL). This study aimed to investigate the hypothesis that TACE would be elevated in the gingival crevicular fluid (GCF) of persons with periodontitis. Total TACE amounts in GCF were higher in persons with chronic and aggressive periodontitis than in those with gingivitis or in healthy persons. TACE concentrations in GCF were higher in persons with chronic and aggressive periodontitis than in those with gingivitis, although not significantly higher than in healthy persons. Persons with chronic periodontitis receiving immunosuppressive treatment exhibited over 10-fold lower TACE levels than the other periodontitis groups. TACE was positively correlated with probing pocket depth, clinical attachment levels, and RANKL concentrations in GCF. In conclusion, the increased GCF TACE levels in persons with periodontitis and their positive correlation with RANKL may indicate an association of this enzyme with alveolar bone loss, and may warrant special attention in future therapeutic approaches.
Get full access to this article
View all access options for this article.
References
1.
Armitage GC -1999-. Development of a classification system for periodontal diseases and conditions. Ann Periodontol4:1–6.
2.
Black RA -2002-. Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol34:1–5.
3.
Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, et al. -1997-. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature385:729–733.
4.
Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Toz H, et al. -2007a-. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol34:370–376.
5.
Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Toz H, et al. -2007b-. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontal Res42:287–293.
6.
Burrage PS, Brinckerhoff CE -2007-. Molecular targets in osteoarthritis: metalloproteinases and their inhibitors. Curr Drug Targets8:293–303.
7.
Chung RM, Grbic JT, Lamster IB -1997-. Interleukin-8 and beta-glucuron-idase in gingival crevicular fluid. J Clin Periodontol24:146–152.
8.
Crotti T, Smith MD, Hirsch R, Soukoulis S, Weedon H, Capone M, et al. -2003-. Receptor activator NF kappaB ligand -RANKL- and osteoprotegerin -OPG- protein expression in periodontitis. J Periodontal Res38:380–387.
9.
Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS -2004-. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol31:671–679.
10.
Han X, Kawai T, Eastcott JW, Taubman MA -2006-. Bacterial-responsive B lymphocytes induce periodontal bone resorption. J Immunol176:625–631.
11.
Horiki M, Nakase T, Myoui A, Sugano N, Nishii T, Tomita T, et al. -2004-. Localization of RANKL in osteolytic tissue around a loosened joint prosthesis. J Bone Miner Metab22:346–351.
12.
Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, et al. -2006-. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol169:987–998.
13.
Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, et al. -1999-. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature402:304–309.
14.
Lamster IB, Holmes LG, Gross KB, Oshrain RL, Cohen DW, Rose LF, et al. -1994-. The relationship of beta-glucuronidase activity in crevicular fluid to clinical parameters of periodontal disease. Findings from a multicenter study. J Clin Periodontol21:118–127.
15.
Liu D, Xu JK, Figliomeni L, Huang L, Pavlos NJ, Rogers M, et al. -2003-. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med11:17–21.
16.
Lu HK, Chen YL, Chang HC, Li CL, Kuo MY -2006-. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodontal Res41:354–360.
17.
Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlondorff J, et al. -1999-. Evidence for a role of a tumor necrosis factor-alpha -TNF-alpha--converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem274:13613–13618.
18.
Mizuno A, Kanno T, Hoshi M, Shibata O, Yano K, Fujise N, et al. -2002-. Transgenic mice overexpressing soluble osteoclast differentiation factor -sODF- exhibit severe osteoporosis. J Bone Miner Metab20:337–344.
19.
Mogi M, Otogoto J, Ota N, Togari A -2004-. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res83:166–169.
20.
Moss ML, Bartsch JW -2004-. Therapeutic benefits from targeting of ADAM family members. Biochemistry43:7227–7235.
21.
Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, et al. -1997-. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature385:733–736; erratum in Nature 386:738, 1997.
22.
Nakamichi Y, Udagawa N, Kobayashi Y, Nakamura M, Yamamoto Y, Yamashita T, et al. -2007-. Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand derived from osteoblasts. J Immunol178:192–200.
23.
Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, et al. -2000-. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun275:768–775.
24.
Nishijima Y, Yamaguchi M, Kojima T, Aihara N, Nakajima R, Kasai K -2006-. Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro. Orthod Craniofac Res9:63–70.
25.
Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, et al. -2000-. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem275:14608–14614.
26.
Schlondorff J, Lum L, Blobel CP -2001-. Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase. J Biol Chem276:14665–14674.
27.
Taubman MA, Valverde P, Han X, Kawai T -2005-. Immune response: the key to bone resorption in periodontal disease. J Periodontol76-11 Suppl-:2033S–2041S.
28.
Taubman MA, Kawai T, Han X -2007-. The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies. J Clin Periodontol34:367–369.
29.
Teitelbaum SL -2000-. Bone resorption by osteoclasts. Science289:1504–1508.
30.
Teng YT -2006-. Protective and destructive immunity in the periodontium: Part 2—T-cell-mediated immunity in the periodontium. J Dent Res85:209–219; erratum in J Dent Res 85:384, 2006.
31.
Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, et al. -2000-. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest106:59–67.
32.
Uitto VJ, Overall CM, McCulloch C -2003-. Proteolytic host cell enzymes in gingival crevice fluid. Periodontol 200031:77–104.
33.
Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA, Gamonal J -2004-. Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. J Periodontol75:1586–1591.
34.
Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R -2001-. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. J Bone Miner Res16:328–337.
35.
Zhang Z, Cork J, Ye P, Lei D, Schwarzenberger PO, Summer WR, et al. -2000-. Inhibition of TNF-alpha processing and TACE-mediated ectodomain shedding by ethanol. J Leukoc Biol67:856–862.
